{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:14:54Z","timestamp":1792815294217,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001381","name":"National Research Foundation Singapore","doi-asserted-by":"publisher","award":["CRP28-2022RS-0001"],"award-info":[{"award-number":["CRP28-2022RS-0001"]}],"id":[{"id":"10.13039\/501100001381","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-73512-3","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:46:03Z","timestamp":1780569963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antioxidant lipid nanoparticles enhance mRNA stability for regeneration therapy and gene editing"],"prefix":"10.1038","volume":"17","author":[{"given":"Benhao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2238-6875","authenticated-orcid":false,"given":"Mengyao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4136-3084","authenticated-orcid":false,"given":"Bowei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taihua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengqing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9622-0870","authenticated-orcid":false,"given":"Xiaoyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1871-5448","authenticated-orcid":false,"given":"Yi Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3990-5248","authenticated-orcid":false,"given":"Ling","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4230-5059","authenticated-orcid":false,"given":"Qianqian","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"73512_CR1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41586-024-07465-2","volume":"630","author":"C Gribben","year":"2024","unstructured":"Gribben, C. et al. Acquisition of epithelial plasticity in human chronic liver disease. Nature 630, 166\u2013173 (2024).","journal-title":"Nature"},{"key":"73512_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41575-023-00846-4","volume":"21","author":"G Feng","year":"2024","unstructured":"Feng, G. et al. Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease. Nat. Rev. Gastroenterol. Hepatol. 21, 46\u201356 (2024).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"73512_CR3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s40257-025-00949-5","volume":"26","author":"D Ranzinger","year":"2025","unstructured":"Ranzinger, D. & Eyerich, K. Disease modification in psoriasis: future prospects for long-term remission. Am. J. Clin. Dermatol. 26, 477\u2013486 (2025).","journal-title":"Am. J. Clin. Dermatol."},{"key":"73512_CR4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41591-024-03489-3","volume":"31","author":"MMA Verstegen","year":"2025","unstructured":"Verstegen, M. M. A. et al. Clinical applications of human organoids. Nat. Med. 31, 409\u2013421 (2025).","journal-title":"Nat. Med."},{"key":"73512_CR5","doi-asserted-by":"publisher","first-page":"115347","DOI":"10.1016\/j.addr.2024.115347","volume":"211","author":"H Capella-Monson\u00eds","year":"2024","unstructured":"Capella-Monson\u00eds, H., Crum, R. J., Hussey, G. S. & Badylak, S. F. Advances, challenges, and future directions in the clinical translation of ECM biomaterials for regenerative medicine applications. Adv. Drug Deliver. Rev. 211, 115347 (2024).","journal-title":"Adv. Drug Deliver. Rev."},{"key":"73512_CR6","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/S0140-6736(23)02444-3","volume":"403","author":"H Parhiz","year":"2024","unstructured":"Parhiz, H., Atochina-Vasserman, E. N. & Weissman, D. mRNA-based therapeutics: looking beyond COVID-19 vaccines. Lancet 403, 1192\u20131204 (2024).","journal-title":"Lancet"},{"key":"73512_CR7","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/s41591-024-02816-y","volume":"30","author":"P Peretti-Watel","year":"2024","unstructured":"Peretti-Watel, P., Verger, P. & Ward, J. K. To understand mRNA vaccine hesitancy, stop calling the public anti-science. Nat. Med. 30, 923\u2013924 (2024).","journal-title":"Nat. Med."},{"key":"73512_CR8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41587-024-02174-7","volume":"43","author":"H Chen","year":"2025","unstructured":"Chen, H. et al. Branched chemically modified poly(A) tails enhance the translation capacity of mRNA. Nat. Biotechnol. 43, 194\u2013203 (2025).","journal-title":"Nat. Biotechnol."},{"key":"73512_CR9","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1038\/s41565-024-01765-4","volume":"19","author":"S Zhao","year":"2024","unstructured":"Zhao, S. et al. Acid-degradable lipid nanoparticles enhance the delivery of mRNA. Nat. Nanotechnol. 19, 1702\u20131711 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"73512_CR10","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1038\/s41557-024-01557-2","volume":"16","author":"X Han","year":"2024","unstructured":"Han, X. et al. Fast and facile synthesis of amidine-incorporated degradable lipids for versatile mRNA delivery in vivo. Nat. Chem. 16, 1687\u20131697 (2024).","journal-title":"Nat. Chem."},{"key":"73512_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51571-8","volume":"15","author":"X Shan","year":"2024","unstructured":"Shan, X. et al. RNA nanotherapeutics with fibrosis overexpression and retention for MASH treatment. Nat. Commun. 15, 7263 (2024).","journal-title":"Nat. Commun."},{"key":"73512_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.abm0594","volume":"375","author":"JG Rurik","year":"2022","unstructured":"Rurik, J. G. et al. CAR T cells produced in vivo to treat cardiac injury. Science 375, 91\u201396 (2022).","journal-title":"Science"},{"key":"73512_CR13","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1039\/D3CS00194F","volume":"53","author":"H Zhang","year":"2024","unstructured":"Zhang, H., Vandesompele, J., Braeckmans, K., De Smedt, S. C. & Remaut, K. Nucleic acid degradation as barrier to gene delivery: a guide to understand and overcome nuclease activity. Chem. Soc. Rev. 53, 317\u2013360 (2024).","journal-title":"Chem. Soc. Rev."},{"key":"73512_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41576-023-00645-2","volume":"25","author":"S Delaunay","year":"2024","unstructured":"Delaunay, S., Helm, M. & Frye, M. RNA modifications in physiology and disease: towards clinical applications. Nat. Rev. Genet. 25, 104\u2013122 (2024).","journal-title":"Nat. Rev. Genet."},{"key":"73512_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.18609\/nai.2024.015","volume":"1","author":"J Zhai","year":"2024","unstructured":"Zhai, J., Cote, T. & Chen, Y. Challenges and advances of the stability of mRNA delivery therapeutics. Nucl. Acid Insights 1, 101\u2013113 (2024).","journal-title":"Nucl. Acid Insights"},{"key":"73512_CR16","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.celrep.2014.10.042","volume":"9","author":"CL Simms","year":"2014","unstructured":"Simms, C. L., Hudson, B. H., Mosior, J. W., Rangwala, A. S. & Zaher, H. S. An active role for the ribosome in determining the fate of oxidized mRNA. Cell Rep. 9, 1256\u20131264 (2014).","journal-title":"Cell Rep"},{"key":"73512_CR17","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1021\/acs.chemrev.3c00611","volume":"124","author":"Y Shi","year":"2024","unstructured":"Shi, Y. et al. Chemically modified platforms for better RNA therapeutics. Chem. Rev. 124, 929\u20131033 (2024).","journal-title":"Chem. Rev."},{"key":"73512_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","volume":"15","author":"Q Cheng","year":"2020","unstructured":"Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing. Nat. Nanotechnol. 15, 313\u2013320 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"73512_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41565-024-01747-6","volume":"20","author":"L Xue","year":"2025","unstructured":"Xue, L. et al. Combinatorial design of siloxane-incorporated lipid nanoparticles augments intracellular processing for tissue-specific mRNA therapeutic delivery. Nat. Nanotechnol. 20, 132\u2013143 (2025).","journal-title":"Nat. Nanotechnol."},{"key":"73512_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202303370","volume":"35","author":"MHY Cheng","year":"2023","unstructured":"Cheng, M. H. Y. et al. Induction of Bleb structures in lipid nanoparticle formulations of mRNA leads to improved transfection potency. Adv. Mater. 35, e2303370 (2023).","journal-title":"Adv. Mater."},{"key":"73512_CR21","doi-asserted-by":"publisher","first-page":"5978","DOI":"10.3390\/molecules29245978","volume":"29","author":"IV Kornienko","year":"2024","unstructured":"Kornienko, I. V., Aramova, O. Y., Tishchenko, A. A., Rudoy, D. V. & Chikindas, M. L. RNA Stability: a review of the role of structural features and environmental conditions. Molecules 29, 5978 (2024).","journal-title":"Molecules"},{"key":"73512_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26926-0","volume":"12","author":"M Packer","year":"2021","unstructured":"Packer, M., Gyawali, D., Yerabolu, R., Schariter, J. & White, P. A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems. Nat. Commun. 12, 6777 (2021).","journal-title":"Nat. Commun."},{"key":"73512_CR23","doi-asserted-by":"publisher","first-page":"11679","DOI":"10.1021\/jacs.3c14010","volume":"146","author":"K Yang","year":"2024","unstructured":"Yang, K. et al. Biodegradable lipid-modified poly(guanidine thioctic acid)s: a fortifier of lipid nanoparticles to promote the efficacy and safety of mRNA cancer vaccines. J. Am. Chem. Soc. 146, 11679\u201311693 (2024).","journal-title":"J. Am. Chem. Soc."},{"key":"73512_CR24","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.3390\/pharmaceutics14112357","volume":"14","author":"M Kamiya","year":"2022","unstructured":"Kamiya, M. et al. Stability study of mRNA-lipid nanoparticles exposed to various conditions based on the evaluation between physicochemical properties and their relation with protein expression ability. Pharmaceutics 14, 2357 (2022).","journal-title":"Pharmaceutics"},{"key":"73512_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41573-023-00827-x","volume":"23","author":"M Metkar","year":"2024","unstructured":"Metkar, M., Pepin, C. S. & Moore, M. J. Tailor made: the art of therapeutic mRNA design. Nat. Rev. Drug Discov. 23, 67\u201383 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"73512_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","volume":"55","author":"Y Eygeris","year":"2022","unstructured":"Eygeris, Y., Gupta, M., Kim, J. & Sahay, G. Chemistry of lipid nanoparticles for RNA delivery. Acc. Chem. Res. 55, 2\u201312 (2022).","journal-title":"Acc. Chem. Res."},{"key":"73512_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/vaccines9010065","volume":"9","author":"MD Buschmann","year":"2021","unstructured":"Buschmann, M. D. et al. Nanomaterial delivery systems for mRNA vaccines. Vaccines 9, 65 (2021).","journal-title":"Vaccines"},{"key":"73512_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/17425247.2023.2162876","volume":"20","author":"A De","year":"2023","unstructured":"De, A. & Ko, Y. T. Why mRNA-ionizable LNPs formulations are so short-lived: causes and way-out. Expert Opin. Drug Deliv. 20, 175\u2013187 (2023).","journal-title":"Expert Opin. Drug Deliv."},{"key":"73512_CR29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2309472120","volume":"120","author":"J Chen","year":"2023","unstructured":"Chen, J. et al. Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA delivery with minimized off-target effects. Proc. Natl. Acad. Sci. USA. 120, e2309472120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73512_CR30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41565-025-02114-9","volume":"21","author":"B Yang","year":"2026","unstructured":"Yang, B. et al. Rational design of rigid mRNA folding architecture to enhance intracellular processing and protein production. Nat. Nanotechnol.\u00a021, 407\u2013418 (2026).","journal-title":"Nat. Nanotechnol."},{"key":"73512_CR31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2311700120","volume":"121","author":"G Tesei","year":"2024","unstructured":"Tesei, G. et al. Lipid shape and packing are key for optimal design of pH-sensitive mRNA lipid nanoparticles. Proc. Natl. Acad. Sci. USA. 121, e2311700120 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73512_CR32","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41563-020-00886-0","volume":"20","author":"S Liu","year":"2021","unstructured":"Liu, S. et al. Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR\u2013Cas gene editing. Nat. Mater. 20, 701\u2013710 (2021).","journal-title":"Nat. Mater."},{"key":"73512_CR33","doi-asserted-by":"publisher","first-page":"4787","DOI":"10.1021\/acsnano.8b01516","volume":"12","author":"JA Kulkarni","year":"2018","unstructured":"Kulkarni, J. A. et al. On the formation and morphology of lipid nanoparticles containing ionizable cationic lipids and siRNA. ACS Nano 12, 4787\u20134795 (2018).","journal-title":"ACS Nano"},{"key":"73512_CR34","doi-asserted-by":"publisher","first-page":"4916","DOI":"10.1021\/jp037247d","volume":"108","author":"M Leopoldini","year":"2004","unstructured":"Leopoldini, M., Marino, T., Russo, N. & Toscano, M. Antioxidant properties of phenolic compounds:\u2009 H-atom versus electron transfer mechanism. J. Phys. Chem. A 108, 4916\u20134922 (2004).","journal-title":"J. Phys. Chem. A"},{"key":"73512_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202302676","volume":"62","author":"B Li","year":"2023","unstructured":"Li, B. et al. Activatable NIR-II photothermal lipid nanoparticles for improved messenger RNA delivery. Angew. Chem. Int. Ed. 62, e202302676 (2023).","journal-title":"Angew. Chem. Int. Ed."},{"key":"73512_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-20903-3","volume":"12","author":"F Rizvi","year":"2021","unstructured":"Rizvi, F. et al. Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA. Nat. Commun. 12, 613 (2021).","journal-title":"Nat. Commun."},{"key":"73512_CR37","doi-asserted-by":"publisher","first-page":"101436","DOI":"10.1016\/j.omtm.2025.101436","volume":"33","author":"M Hosseini-Kharat","year":"2025","unstructured":"Hosseini-Kharat, M., Bremmell, K. E. & Prestidge, C. A. Why do lipid nanoparticles target the liver? Understanding of biodistribution and liver-specific tropism. Mol. Ther. Meth. Clin. D. 33, 101436 (2025).","journal-title":"Mol. Ther. Meth. Clin. D."},{"key":"73512_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202409812","volume":"36","author":"Y Fei","year":"2024","unstructured":"Fei, Y. et al. Simplified lipid nanoparticles for tissue- and cell-targeted mRNA delivery facilitate precision tumor therapy in a lung metastasis mouse model. Adv. Mater. 36, e2409812 (2024).","journal-title":"Adv. Mater."},{"key":"73512_CR39","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1038\/s41591-020-1102-2","volume":"26","author":"AA Kolodziejczyk","year":"2020","unstructured":"Kolodziejczyk, A. A. et al. Acute liver failure is regulated by MYC- and microbiome-dependent programs. Nat. Med. 26, 1899\u20131911 (2020).","journal-title":"Nat. Med."},{"key":"73512_CR40","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.jhep.2021.08.011","volume":"75","author":"T Yang","year":"2021","unstructured":"Yang, T. et al. Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model. J. Hepatol. 75, 1420\u20131433 (2021).","journal-title":"J. Hepatol."},{"key":"73512_CR41","doi-asserted-by":"publisher","first-page":"588","DOI":"10.2183\/pjab.86.588","volume":"86","author":"T Nakamura","year":"2010","unstructured":"Nakamura, T. & Mizuno, S. The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. Proc. Jpn. Acad. Ser. B 86, 588\u2013610 (2010).","journal-title":"Proc. Jpn. Acad. Ser. B"},{"key":"73512_CR42","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/5593","volume":"5","author":"T Ueki","year":"1999","unstructured":"Ueki, T. et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat. Med. 5, 226\u2013230 (1999).","journal-title":"Nat. Med."},{"key":"73512_CR43","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/jdi.12904","volume":"10","author":"Y Jing","year":"2019","unstructured":"Jing, Y. et al. Hepatocyte growth factor alleviates hepatic insulin resistance and lipid accumulation in high-fat diet-fed mice. J. Diabetes Investig. 10, 251\u2013260 (2019).","journal-title":"J. Diabetes Investig."},{"key":"73512_CR44","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","volume":"20","author":"L Hammerich","year":"2023","unstructured":"Hammerich, L. & Tacke, F. Hepatic inflammatory responses in liver fibrosis. Nat. Rev. Gastroenterol. Hepatol. 20, 633\u2013646 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"73512_CR45","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","volume":"575","author":"P Ramachandran","year":"2019","unstructured":"Ramachandran, P. et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature 575, 512\u2013518 (2019).","journal-title":"Nature"},{"key":"73512_CR46","doi-asserted-by":"publisher","first-page":"101512","DOI":"10.1016\/j.molmet.2022.101512","volume":"61","author":"S Lecoutre","year":"2022","unstructured":"Lecoutre, S. et al. Beta-hydroxybutyrate dampens adipose progenitors\u2019 profibrotic activation through canonical Tgfbeta signaling and non-canonical ZFP36-dependent mechanisms. Mol. Metab. 61, 101512 (2022).","journal-title":"Mol. Metab."},{"key":"73512_CR47","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.3390\/antiox12101800","volume":"12","author":"D Zou","year":"2023","unstructured":"Zou, D. et al. DUOX2-induced oxidative stress inhibits intestinal angiogenesis through MMP3 in a low-birth-weight piglet model. Antioxidants 12, 1800 (2023).","journal-title":"Antioxidants"},{"key":"73512_CR48","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1089\/ars.2013.5619","volume":"20","author":"YH Paik","year":"2014","unstructured":"Paik, Y. H. et al. Role of NADPH oxidases in liver fibrosis. Antioxid. Redox Signal. 20, 2854\u20132872 (2014).","journal-title":"Antioxid. Redox Signal."},{"key":"73512_CR49","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s11658-024-00631-4","volume":"29","author":"X Deng","year":"2024","unstructured":"Deng, X. et al. Paeoniflorin protects hepatocytes from APAP-induced damage through launching autophagy via the MAPK\/mTOR signaling pathway. Cell. Mol. Biol. Lett. 29, 119 (2024).","journal-title":"Cell. Mol. Biol. Lett."},{"key":"73512_CR50","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.jhep.2019.06.019","volume":"71","author":"HG Kim","year":"2019","unstructured":"Kim, H. G. et al. The epigenetic regulator SIRT6 protects the liver from alcohol-induced tissue injury by reducing oxidative stress in mice. J. Hepatol. 71, 960\u2013969 (2019).","journal-title":"J. Hepatol."},{"key":"73512_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42477-y","volume":"14","author":"X Lu","year":"2023","unstructured":"Lu, X. et al. Single-atom catalysts-based catalytic ROS clearance for efficient psoriasis treatment and relapse prevention via restoring ESR1. Nat. Commun. 14, 6767 (2023).","journal-title":"Nat. Commun."},{"key":"73512_CR52","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-025-00630-5","volume":"11","author":"AW Armstrong","year":"2025","unstructured":"Armstrong, A. W. et al. Psoriasis. Nat. Rev. Dis. Primers 11, 45 (2025).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"73512_CR53","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adl4336","volume":"10","author":"E Tan","year":"2024","unstructured":"Tan, E. et al. Dual-responsive nanocarriers for efficient cytosolic protein delivery and CRISPR-Cas9 gene therapy of inflammatory skin disorders. Sci. Adv. 10, eadl4336 (2024).","journal-title":"Sci. Adv."},{"key":"73512_CR54","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1038\/s41590-025-02230-7","volume":"26","author":"ANR Weber","year":"2025","unstructured":"Weber, A. N. R. et al. The expanding role of the NLRP3 inflammasome from periodic fevers to therapeutic targets. Nat. Immunol. 26, 1453\u20131466 (2025).","journal-title":"Nat. Immunol."},{"key":"73512_CR55","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41587-025-02556-5","volume":"44","author":"MN Patel","year":"2026","unstructured":"Patel, M. N. et al. Safer non-viral DNA delivery using lipid nanoparticles loaded with endogenous anti-inflammatory lipids. Nat. Biotechnol. 44, 79\u201389 (2026).","journal-title":"Nat. Biotechnol."},{"key":"73512_CR56","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1038\/s41551-025-01422-8","volume":"9","author":"N Gong","year":"2025","unstructured":"Gong, N. et al. Mannich reaction-based combinatorial libraries identify antioxidant ionizable lipids for mRNA delivery with reduced immunogenicity. Nat. Biomed. Eng. 9, 2181\u20132195 (2025).","journal-title":"Nat. Biomed. Eng."},{"key":"73512_CR57","doi-asserted-by":"publisher","unstructured":"Xue, Y. et al. Antimicrobial peptide delivery to lung as peptibody mRNA in anti-inflammatory lipids treats multidrug-resistant bacterial pneumonia. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-025-02928-x (2025).","DOI":"10.1038\/s41587-025-02928-x"},{"key":"73512_CR58","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","volume":"18","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery. Nat. Protoc. 18, 265\u2013291 (2023).","journal-title":"Nat. Protoc."},{"key":"73512_CR59","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ejphar.2011.08.029","volume":"674","author":"R Yang","year":"2012","unstructured":"Yang, R. et al. Suppression of NF-kappaB pathway by crocetin contributes to attenuation of lipopolysaccharide-induced acute lung injury in mice. Eur. J. Pharmacol. 674, 391\u2013396 (2012).","journal-title":"Eur. J. Pharmacol."},{"key":"73512_CR60","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1016\/j.ymthe.2024.09.008","volume":"32","author":"S Shen","year":"2024","unstructured":"Shen, S. et al. CasRx-based Wnt activation promotes alveolar regeneration while ameliorating pulmonary fibrosis in a mouse model of lung injury. Mol. Ther. 32, 3974\u20133989 (2024).","journal-title":"Mol. Ther."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73512-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73512-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73512-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T23:12:16Z","timestamp":1784848336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73512-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["73512"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-73512-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"X.C. is a co-founder of and holds shares in Yantai Lannacheng Biotechnology Co., Ltd. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"7166"}}